Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial

Hydroxychloroquine (HCQ) is an antimalarial agent used to treat mucocutaneous, musculoskeletal, constitutional manifestations of systemic lupus erythematosus (SLE). This study assessed the efficacy and side effects of HCQ in children with proliferative lupus nephritis (LN). This double-blind, random...

Descripción completa

Detalles Bibliográficos
Autores principales: Gheet, Fatma Sayed, Dawoud, Heba El-Sayed, El-Shahaby, Waleed Ahmed, Elrifaey, Shymaa Mohamed, Abdelnabi, Hend Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167107/
https://www.ncbi.nlm.nih.gov/pubmed/36752895
http://dx.doi.org/10.1007/s00431-023-04837-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167107/
https://www.ncbi.nlm.nih.gov/pubmed/36752895
http://dx.doi.org/10.1007/s00431-023-04837-0

Ejemplares similares